JERUSALEM, Jan. 6, 2025 /PRNewswire/ -- Scinai Immunotherapeutics Ltd. (Nasdaq: SCNI) ("Scinai" or the "Company"), a biopharmaceutical company specializing in inflammation and immunology (I&I) biological products and offering CDMO services through its Scinai Bioservices unit, announced...
Read More Details
Finally We wish PressBee provided you with enough information of ( Scinai to Connect with Investors and Pharma Leaders at Upcoming Key US Conferences )
Also on site :
- Adidas Has 'Sleek' $180 Running Shoes for Just $90, and Reviewers Say They Feel Like They’re 'Walking On Clouds'
- Legendary '60s Rock Band Released a Song 45 Years Ago That Led to Their Split
- Taylor Swift’s Bestie Beams in Rare Sighting With New Husband: ‘He Seems So Sweet’